19th Annual Psychopharmacology Update | CME Program Schedule

Psychopharmacology Update

Child, Adolescent & Parenting Pre-conference | Evidence Based Treatment Guidelines Post-conference


  Thursday, February 13 Friday, February 14 Saturday, February 15
7:00-
8:00 am
Breakfast with Exhibitors
Breakfast with Exhibitors Breakfast
8:00-
9:00 am

Neurodevelopmental Disorders
James McCracken, MD
Professor, Director of Child and Adolescent Psychiatry
David Geffen School of Medicine at UCLA

Read bio

Prescribing Drugs to Make Criminals Eligible for Punishment: A Violation of Medical Ethics?
Douglas Mossman, MD

Professor of Psychiatry
University of Cincinnati College of Medicine


Read bio

Depressive Disorders
Faculty to be announced

9:00-
10:00 am

Feeding and Eating Disorders: How is pharmacotherapy effective?
Katherine Halmi, MD
Professor Emerita
Weill Medical College of Cornell University

Read bio

 

Somatic Symptom Disorders
David Spiegel, MD
Jack, Lulu & Sam Wilson Professor
Stanford University



Depressive Disorders
Jonathan Alpert, MD
Associate Chief of Psychiatry, Massachusetts General Hospital; Joyce R. Tedlow Associate; Professor of Psychiatry
Harvard Medical School


Read bio

10:00-
10:15 am
Networking Break with Exhibitors
Networking Break with Exhibitors Networking Break
10:15-
11:15 am

Current Approaches to Treating Pediatric Mood and Anxiety Disorders
Daniel Pine, NIMH
Senior Psychiatrist
The Ross Center

Read bio

Neurocognitive Disorders
Dylan Wint, MD
Director, Education in Neurodegeneration; Director, Fellowship in Cognitive Disorders
Cleveland Clinic Lou Ruvo Center for Brain Health

Read bio

Bipolar and Related Disorders
Roger McIntyre, MD
Professor of Psychiatry and Pharmacology
University of Toronto

Read bio

11:15-
12:15 pm

Disruptive, Impulse Control, and Conduct Disorders
James McCracken, MD
Professor, Director of Child and Adolescent Psychiatry
David Geffen School of Medicine at UCLA

Read bio

Psychopharmacological Management of Sleep/Wake Disorders
Karl Doghramji, MD
Professor os Psychiatry, Neurology, and Medicine; Medical Director, Jefferson Sleep Disorders Center; Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University

Read bio

Bipolar and Related Disorders
Roger McIntyre, MD
Professor of Psychiatry and Pharmacology
University of Toronto

Read bio

12:15-
1:30 pm

Lunch
1:30-
2:30 pm

Attacking Anxiety Disorders
Murray Stein, MD, MPH
Professor of Psychiatry and Family & Preventative Medicine
University of California San Diego

Read bio

Hypersexual Disorder: A guide for the clinician and psychopharmacologist
Martin Kafka, MD
Clinical Associate Professor of Psychiatry
Harvard Medical School

Read bio

New Medications for Addictive Disorders and the Effect of Health Care Reform
Charles P. O'Brien, MD, PhD
Professor and Director, Center for Studies of Addiction
University of Pennsylvania

Read bio

2:30-
3:30 pm
Post-traumatic Stress Disorder: When Remembering Hurts
Murray Stein, MD, MPH
Professor of Psychiatry and Family & Preventative Medicine
University of California San Diego


Read bio

Treating Transgender Children and Adolescents: From Cross-Dressing to Puberty-Suppressing Drugs
Jack Drescher, MD
Clinical Associate Professor of Psychiatry
New York Medical College

Read bio

Substance Use and Addictive Disorders
Mark Schuckit, MD
Distinguished Professor of Psychiatry
University of California San Diego

Read bio

3:30-
3:45 pm
Networking Break with Exhibitors
Networking Break with Exhibitors Networking Break
3:45-
4:45 pm

Schizophrenia Spectrum: New paradigms for treatment and prevention
William Carpenter, MD
Professor of Psychiatry and Pharmacology
University of Maryland School of Medicine

Read bio

Psychopharmacology of Paraphilic Disorders
Douglas E. Tucker, MD
Associate Clinical Professor, Department of Psychiatry
University of California

Read bio

Treatment of OCD in Office Practice
John T. Walkup, MD

Director of Child and Adolescent Psychiatry
New York Presbyterian and Weill Cornell Medical College

Read bio

4:45-
5:45pm
Schizophrenia Spectrum: Attenuated Psychosis Syndrome
Faculty to be announced

Personality Disorders and DSM-5
John Oldham, MD
Senior Vice President and Chief of Staff, The Menninger Clinic; Professor and Executive Vice Chair, Menninger Department of Psychiatry& Behavioral Sciences
Baylor College of Medicine


Read bio

Advances in Detection and Treatment of Dissociative Symptoms and Disorders
Marlene Steinberg, MD
Private Clinical Practice, Naples Florida
Formerly Associate Research Scientist
Yale School of Medicine


Read bio

 

Welcome Reception in Exhibit Hall | Thursday, February 13, 5:45 - 7:00 pm
Please join us for complimentary appetizers and beverages in the Exhibit Hall to kick off the
NPA 19th Annual Psychopharmacology Update!

Accreditation

CME Credit is pending approval.

Disclosure

It is the policy of NPA and UNSOM to comply with the ACCME standards for commercial support of CME. Planning Committee members and related staff disclosures must be on file annually with disclosures made available on program materials. Faculty participating in jointly sponsored programs by UNSOM are required to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation. Faculty also are responsible for disclosing any discussion of off-label or investigational use of a product.

In accordance with the ACCME requirements on disclosure, information about relationships of presenters with commercial interests, if any, will be included in materials distributed at the time of the conference.

General Course Information

The NPA 19th Annual Psychopharmacology Update is a nonsmoking event. Spouses, guests, infants, and/or children are not allowed in the meeting room or exhibit hall. Cell phones, pagers, and PDAs must be turned off during educational sessions. Please be courteous to your fellow attendees. Dress is business casual. Nevada Psychiatric Association reserves the right to substitute faculty or to cancel or reschedule sessions due to unforeseen circumstances.

 
powered by MemberClicks